Table 4.
Effect of manuka honey on cell cycle progression of the gastric mucosal cells.
Treatment regimen | Sub-G1% | G1% | S-phase% | G2M% |
---|---|---|---|---|
SHAM | 4.39 ± 0.93 | 81.48 ± 2.46 | 6.70 ± 1.16 | 6.89 ± 1.04 |
Ulcer control group | 24.39 ± 5.13a | 57.82 ± 5.42a | 10.40 ± 1.49a | 7.93 ± 1.52a |
Ulcer group + ranitidine (30 mg/kg) | 20.36 ± 4.75b | 64.01 ± 7.33b | 8.69 ± 2.26b | 1.95 ± 0.29b |
Ulcer group + manuka honey (2.5 gm/kg) | 4.91 ± 1.12b | 84.83 ± 1.87b | 3.78 ± 0.70b | 4.13 ± 0.61b |
Data are mean ± SEM (n = 6).
aSignificant versus SHAM (P ≤ 0.05).
bSignificant versus acetic acid (ulcer) (P ≤ 0.05).